CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+12.14%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.2B
AUM Growth
+$1.2B
(+21%)
Cap. Flow
+$55.1M
Cap. Flow
% of AUM
4.61%
Top 10 Holdings %
Top 10 Hldgs %
53.06%
Holding
46
New
8
Increased
14
Reduced
6
Closed
6
Top Buys
| 1 |
Labcorp
LH
|
$54M |
| 2 |
MDCO
Medicines Co
MDCO
|
$36.5M |
| 3 |
Boston Scientific
BSX
|
$33.1M |
| 4 |
KND
Kindred Healthcare
KND
|
$27.3M |
| 5 |
GSK
GSK
|
$23.5M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$44.9M |
| 2 |
VOLC
VOLCANO CORPORATION COM STK
VOLC
|
$44.7M |
| 3 |
Viatris
VTRS
|
$36.6M |
| 4 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$32.4M |
| 5 |
Quest Diagnostics
DGX
|
$20.3M |
Sector Composition
| 1 | Healthcare | 74.81% |
| 2 | Consumer Discretionary | 2.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $101M | 6.69% | 1,750,000 | – | – |
|
2
Masimo
MASI
$7.59B
| $75.1M | 4.99% | 2,850,000 +150,000 | +6% | +$3.95M |
|
|
3
GSK
GSK
$79.9B
| $74.8M | 4.97% | 1,750,000 +550,000 | +46% | +$23.5M |
|
|
GHDX
4
DELISTED
Genomic Health, Inc.
GHDX
| $68.7M | 4.57% | 2,150,000 +150,000 | +8% | +$4.8M |
|
5
CONMED
CNMD
$1.68B
| $62.3M | 4.14% | 1,385,000 | – | – |
|
|
ESRX
6
DELISTED
Express Scripts Holding Company
ESRX
| $59.3M | 3.94% | 700,000 | – | – |
|
|
7
Labcorp
LH
$23.1B
| $54M | 3.59% | +500,000 | New | +$54M |
|
|
ARIA
8
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $51.5M | 3.43% | 7,500,000 +1,500,000 | +25% | +$10.3M |
|
|
VOLC
9
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $45.6M | 3.03% | 2,550,000 -2,500,000 | -50% | -$44.7M |
|
|
AMAG
10
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $42.6M | 2.83% | 1,000,000 +250,000 | +33% | +$10.7M |
|
|
KERX
11
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $42.5M | 2.82% | 3,000,000 -500,000 | -14% | -$7.08M |
|
|
UAM
12
DELISTED
Universal American Corp
UAM
| $42.4M | 2.82% | 4,568,898 +390,639 | +9% | +$3.63M |
|
|
13
Viatris
VTRS
$12.3B
| $42.3M | 2.81% | 750,000 -650,000 | -46% | -$36.6M |
|
14
Bruker
BRKR
$5.16B
| $39.2M | 2.61% | 2,000,000 +1,000,000 | +100% | +$19.6M |
|
15
Orthofix Medical
OFIX
$592M
| $37.6M | 2.5% | 1,250,000 +39,836 | +3% | +$1.2M |
|
|
MDCO
16
DELISTED
Medicines Co
MDCO
| $36.5M | 2.43% | +1,320,000 | New | +$36.5M |
|
|
17
Boston Scientific
BSX
$156B
| $33.1M | 2.2% | +2,500,000 | New | +$33.1M |
|
|
SQNM
18
DELISTED
SEQUENOM INC NEW
SQNM
| $32.4M | 2.15% | 8,750,000 +750,000 | +9% | +$2.78M |
|
|
WW
19
DELISTED
WW International
WW
| $28.5M | 1.89% | 1,146,741 +146,741 | +15% | +$3.65M |
|
|
KND
20
DELISTED
Kindred Healthcare
KND
| $27.3M | 1.81% | +1,500,000 | New | +$27.3M |
|
21
PTC Therapeutics
PTCT
$3.92B
| $27.2M | 1.81% | 525,000 +366,851 | +232% | +$19M |
|
|
GNMK
22
DELISTED
GenMark Diagnostics, Inc
GNMK
| $23.8M | 1.58% | 1,748,100 +840,000 | +93% | +$11.4M |
|
|
ALR
23
DELISTED
Alere Inc
ALR
| $19M | 1.26% | +500,000 | New | +$19M |
|
24
Cross Country Healthcare
CCRN
$438M
| $17.8M | 1.18% | 1,422,565 +422,565 | +42% | +$5.27M |
|
|
TRVN
25
DELISTED
Trevena, Inc.
TRVN
| $17.2M | 1.14% | +2,870,000 | New | +$17.2M |
|